Leaflet NIMOTOP 30mg film-coated tablets

Product code:
W63888002
Quantity:
100
Indicated for:
hypertension
Route of administration:
oral
Substance:
nimodipine (calcium channel blocker)
ATC
C08CA06 — Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives
Nimodipine is a calcium channel blocker primarily used for the prevention and treatment of cerebral vasospasms associated with subarachnoid hemorrhage. It works by relaxing blood vessels in the brain, improving cerebral blood flow.

The medication is administered orally or intravenously, depending on the patient's condition. The dose and duration of treatment are determined by the physician based on the severity of the condition. Common side effects include dizziness, headaches, nausea, and low blood pressure.

Nimodipine is contraindicated in patients with hypersensitivity to the active substance or other calcium channel blockers. It should also be used with caution in patients with severe liver impairment.

This medication is essential for preventing severe neurological complications associated with subarachnoid hemorrhage, contributing to improved outcomes for affected patients.

General data about NIMOTOP 30mg

Substance:
nimodipine
Date of latest medicines list:
01-06-2026
Product code:
W63888002
Concentration:
30mg
Pharmaceutical form:
film-coated tablets
Quantity:
100
Product type:
Original
Price:
78.83 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BAYER AG - GERMANIA
Holder:
BAYER AG - GERMANIA
Number:
2213/2009/02
Shelf life:
5 years

Pharmaceutical forms available for nimodipine

Concentrations available for nimodipine

  • 10mg/50ml
  • 30mg

Compensation lists for NIMOTOP 30mg Bayer

D - Sublist D with 20% discount from the reference price

Price
78.83 RON
Copayment
15.77 RON
Patient
63.06 RON